Search

everythinglearnresearchcommunity

for

Search:↓

Postmenopausal women can experience hairline recession, affecting their quality of life, and more research is needed for treatments.

Many women experience significant hair loss during menopause, and topical minoxidil is an effective treatment.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Women with nonclassic 21-hydroxylase deficiency can have successful pregnancies through IVF, with certain factors affecting their chances.

Selenzin Peptide Active can effectively treat hair loss in postmenopausal women.

Women over forty can maintain skin and hair health with lifestyle and dietary changes.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

The study found that women with PCOS have more and larger ovarian follicles and differences in ovarian structure, but these features alone can't always diagnose PCOS.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

Women with PCOS have more depression and stress due to high androgen levels, not obesity or insulin resistance.

Hormone replacement therapy may improve hair growth in the frontal hairline of postmenopausal women with hair loss.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Black and Hispanic women are more likely to have alopecia areata than white women.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Hair loss in postmenopausal women due to ovarian hyperthecosis is rare, but removing the ovaries can significantly improve the condition.

Resistance training improved BMI and menstrual regularity more in women with PCOS than aerobic training.

Finasteride may help postmenopausal women with hair loss but is not effective for all and should be used cautiously in premenopausal women.

No significant difference in iron deficiency between women with or without hair loss.

Hair loss in women may have multiple causes, and eyebrow regrowth possible with specific injections.

Certain hair straighteners and dyes may increase ovarian cancer risk, especially in African American/Black women.

Metformin can cause hair loss in some women with PCOS.

Magnesium supplements improved quality of life for women with polycystic ovary syndrome, but didn't help with acne, hair loss, or abnormal bleeding.